Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-26 @ 3:11 AM
Study NCT ID:
NCT02623920
Status:
WITHDRAWN
Last Update Posted:
2017-05-19
First Post:
2015-09-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Sponsor:
University of Arizona
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-16
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-17
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-24
First Submit QC Date:
None
Study First Post Date:
2015-12-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-18
Last Update Post Date:
2017-05-19
Last Update Post Date Type:
ACTUAL